PhRMA Should Have Listened to THIS " Guy in a Hoodie "
Last year I suggest that the pharmaceutical industry put some distance between it a"Pharma Bro" Martin Shkreli. I said (here):"Frankly, I'm getting tired of it all. Shkreli had his 15 minutes of fame. Let's move on. It's time for the pharma industry to get its 15 minutes of fame by doing something substantial to distance itself from the likes of Shrkreli."But, I added a caveat:"The mainstream drug industry cannot distance itself from'wolves' like Shkreli merely through better corporate communications."Unfortunately, the drug industry (aka The Pharmaceutical Research and Man...
Source: Pharma Marketing Blog - January 25, 2017 Category: Pharmaceuticals Tags: PhRMA Source Type: blogs
What a CT Scan Can Tell You About Your Lungs
Over the last half century, technology has made possible the probing of the solar system and galaxy beyond. People can instantly correspond with anyone in the world. We can see —in real time—events and phenomena heretofore only reported by second and third hand accounts. Yet with all of the distance breached by modern devices, we are also able to know in detail the goings on inside our own bodies. With the advent of computed tomography (CT) imaging, known familiarly as “CAT scans,” doctors and their patients now get a bird’s eye view of internal organs. This scientific know-how goes beyond simple x-rays to reveal...
Source: ePharma Summit - January 23, 2017 Category: Pharmaceuticals Tags: Anatomy CT Scan Lungs Medical Devices Source Type: blogs
Pfizer's New Viagra TV Ad Has a Unique Mobile " Call to Action "
As reported by FiercePharma (here), Pfizer ’s new TV commercial for Viagra, which encourages patients to text a keyword from their mobile phones to receive special discounts, appears to be " a first " for pharma Marketing.I decided to have some fun with a few stills from the ad: (Source: Pharma Marketing Blog)
Source: Pharma Marketing Blog - January 19, 2017 Category: Pharmaceuticals Tags: Viagra Source Type: blogs
[Exclusive Whitepaper] How Will the Growth of Digital Health Impact Provider & Patient Relationship?
The third of our three-part whitepaper series explores the direct impact that digital health has on provider and patient relationship.With patients more involved, cost increasing and time becoming less limited, the scope of the provider-patient relationship has changed.Patients and providers have begun to complain that the technologies of recent years that were promised to be faster, easier and cheaper, are actually slow, cumbersome and hindering the face-to-face interactions in health settings. So what comes next in repairing and maintaining this significant relationship, and how can digital health and medicines revolutio...
Source: ePharma Summit - January 18, 2017 Category: Pharmaceuticals Tags: Digital Health health marketing patient marketing pharma marketing Source Type: blogs
Does FDA Guidance About Pharma Communications with Payors Open a Path to Off-Label Discussions?
At the November, 2016, FDA public hearing on off-label promotion, representatives of the drug industry made a case for allowing companies to inform payers of off-label uses of their products.Payers “play such a gatekeeping role with respect to patients,” said Kellie Combs, an attorney for Ropes& Gray, who testified at the hearing on behalf of the Medical Information Working Group. “There's a real interest in getting information to payers as soon as possible. ”In addition, certain types of data, like demonstrating a drug's use in subpopulations and sharing pharmacoeconomic data, are examples of informati...
Source: Pharma Marketing Blog - January 18, 2017 Category: Pharmaceuticals Tags: FDA Guidance HCEI off-label promotion Payors Source Type: blogs
[Exclusive Whitepaper] Digital Health Set to Change Provider and Patient Marketing Efforts
Back in December we shared the first of three exclusive whitepapers with the ePharma community.We've got exciting news! We can now share the second exclusive paper of the three-paper series, While the first explored thefuture of digital health, our second paper focuses on how digital health has impacted and changed marketing efforts feared toward the provider and patient.Digital Health solutions are still mostly driven by marketing departments, whether they be novel devices that alter the way we treat rare diseases or commonplace wearable bands that track our activity. In fact, marketing efforts around digital health have ...
Source: ePharma Summit - January 17, 2017 Category: Pharmaceuticals Tags: Digital Health digital marketing health marketing patient marketing Source Type: blogs
Fact Checking Puzzling Criticisms of a " Puzzling " DTC Study Proposed by FDA
I get periodic emails from Bob Ehrlich, Chairman of DTC Perspectives, Inc., giving his opinion on various direct-to-consumer (DTC) advertising issues.Although I often do not agree with Ehrlich on many issues, I value his perspective and often respond to him via this blog (read, for example,"Are We at the Saturation Point Viz-a-Viz Celebrity Pharma Endorsements?"). We've even had a head-to-head podcast debate (listen to"Are Drug Marketers an Endangered Species?").In a recent email missive, Ehrlich calls FDA ’s recently proposed study of deception in DTC ads (read “Another FDA Study: Can HCPs and ...
Source: Pharma Marketing Blog - January 15, 2017 Category: Pharmaceuticals Tags: Bob Ehrlich DTC Advertising FDA Study Source Type: blogs
Top Pharma Companies on Facebook
Back in August, 2011, Facebook opened up comments on ALL pharma pages, which meant that the pharmaceutical industry no longer was able to shut off comments on their product-related pages. Consequently, several companies decided to shut down their pages (read, for example, "Pharma Facebook Pages Being Phased Out" and "Janssen to Shut Down Psoriasis 360 FaceBook Page" ).These days Facebook offers new opportunities and tools for the pharmaceutical industry to do promotions such as disease awareness campaigns (e.g., "Novartis, Queen Latifah,& American Heart Association Team Up on Facebook Live Broadcast" ) and ads that com...
Source: Pharma Marketing Blog - January 12, 2017 Category: Pharmaceuticals Tags: FaceBook Source Type: blogs
FDA Study is Designed to Justify a New BadAd Program for Consumers, IMHO
The FDA plans to do two new studies supposedly to gauge the “ability of consumers and healthcare professionals (HCPs) to independently identify deceptive prescription drug promotion” (see the Federal Register Noticehere).A closer examination of the proposal, however, suggests that the real goal is to promote the Agency's BadAd program and open it up to consumers.TheBad Ad Program is administered by the agency ’s Office of Prescription Drug Promotion (OPDP) in the Center for Drug Evaluation and Research. The program's goal is to help raise awareness among healthcare providers about misleading prescription dru...
Source: Pharma Marketing Blog - January 9, 2017 Category: Pharmaceuticals Tags: FDA Study Source Type: blogs
Technology Disrupting the Digital Health World
There has been a dramatic increase in health technology over the past few years. However, some critics argue that 2016 has seen the greatest rise on digital health technology. These new innovations have disrupted the medical world and are changing the way healthcare is practiced in this day and age. Medical apps and technologies are helping save hospital costs and make healthcare more accessible.Here are some technologies that have changed the digital health game:Star Trek Style TricorderIn the Star Trek movie, a hand-held device, known as the Tricorder, is used to observe and examine unfamiliar environment and to record a...
Source: ePharma Summit - January 6, 2017 Category: Pharmaceuticals Tags: Digital Health digital marketing disruption ePharma IoT mobile patient monitoring Source Type: blogs
ePharma Exclusive Whitepaper: Six Trends in Pharma Marketing
Several weeks ago, ePharma was fortunate in partnering witheConsultancy, a digital marketing agency, to conduct some research on trends in pharma marketing we should be ware of, both past, present and future. What we learned was that, nearly everything healthcare and what pharma marketers did in 2015 is obsolete. The skills and capabilities required for marketers to successfully connect with key audiences (both healthcare providers as well as consumers and patients) are completely new. Here are some trends to explore now and in 2017.Consumer BehaviorPhysician ConnectionsSocial MediaMillennialsElectronic Health Record...
Source: ePharma Summit - December 30, 2016 Category: Pharmaceuticals Source Type: blogs
Pharmaguy's Top Five 2017 New Year's Resolutions for the Pharma Industry
As is my tradition – as well as the tradition for many other editors/pundits – it’s time for me to tell pharma what I’d like to see included in its list of 2017 New Year's Resolutions.Last year I noted that 2015 wasn ’t an especially good year considering that “the media and politicians have found a face for evil pharma and rising drug prices: Martin Shkreli!” (here).It ’s déjà vu all over again! Only this time many more evil pharma faces have come forward including the CEO of Mylan, aka “Pharma Sis” (read “Mylan ‘Gamed the System’ and Refuses to Testify at Senate Hearing About EpiPen Costs ...
Source: Pharma Marketing Blog - December 29, 2016 Category: Pharmaceuticals Tags: Celebrities Drug prices DTC Advertising FDA New Year ' s Resolution off-label PhRMA Guidelines women Source Type: blogs
FDA's Last Licks for 2016: Issues SIX (6) Enforcement Letters in December, So Far!
Click on image for enlarged view.Just when you thought the FDA was finished issuingWarning andUntitled letters for 2016, it issued 2 more - both Untitled letters - last week, bringing the total issued in December to 6! The grand total to date is 11 letters, including 3 Warning letters.I suspect FDA is responding to critical posts such as the one I wrote on 8 December 2016 citing a total of only 8 letters up until that date. A week later I had to update that (here) when the total reached 9 letters for 2016. I characterized that as a"slight uptick" in enforcement compared to 2015 when FDA also issued 9 total letter...
Source: Pharma Marketing Blog - December 28, 2016 Category: Pharmaceuticals Tags: FDA Regulation waring letters YouTube Source Type: blogs
Images Tell the Story of Pharma in 2016
Yes, 2016 was a lousy year for many people and even for the drug industry, but for different reasons. I've already reviewed data from 2016 that document some good news for pharma (see"Charts& Graphs Tell the Story of Pharma in 2016").Another way to look at 2016 is through images. Some of my favorite images from 2016 are collected in the Slideshare presentation embedded below. Click on"Read more" to access a clickable list of references.Pharma Marketing News 2016 Year in Review: Images fromPharmaGuy.comRead more » (Source: Pharma Marketing Blog)
Source: Pharma Marketing Blog - December 27, 2016 Category: Pharmaceuticals Tags: 2016 Source Type: blogs
What's Roche Doing on Pinterest?
What ' s Roche Doing on Pinterest? (Source: Pharma Marketing Blog)
Source: Pharma Marketing Blog - December 22, 2016 Category: Pharmaceuticals Tags: Pinterest Roche Source Type: blogs
